HCA Healthcare lowered its full-year 2026 earnings guidance due to a payer mix shift toward more uninsured patients following changes in health insurance exchange coverage, sending its stock down 14.1%. The company reported preliminary second-quarter 2026 revenue of about US$20.23 billion and net income of about US$1.70 billion, but now expects full-year net income between US$6.3 billion and US$6.7 billion, down from prior expectations. HCA said the unfavorable impact on income before taxes from the payer mix shift will be only partly offset by incremental benefits from Medicaid Supplemental Payment Programs, prompting tighter full-year revenue and earnings ranges. The revision brings earlier concerns about Medicaid volumes, reimbursement complexity, and supplemental program variability into sharper focus, suggesting these policy-driven items may matter more to near-term outcomes than cost savings or expansion projects.
HCA Healthcare, Inc.Payer mix shift toward more uninsured patients reduces revenue per patient, lowering earnings guidance.